Feigon J, Leupin W, Denny W A, Kearns D R
Nucleic Acids Res. 1982 Jan 22;10(2):749-62. doi: 10.1093/nar/10.2.749.
The binding of three ethidium derivatives, ethidium (1), des-3-amino ethidium (2) and des-8-amino ethidium (3), to short (approximately 35 base pairs), random sequence DNA has been investigated using 300 MHz proton NMR. At 35 degrees C all three drugs cause upfield shifts of the resonances from the exchangeable imino protons, as expected for intercalative binding to DNA. However, the lineshapes vary significantly with the nature of the drug. The temperature dependence of the spectra of the DNA shows that differences between spectra observed at 35 degrees C with ethidium and with des-3-amino ethidium are primarily due to differences in the drug binding kinetics rather than to differences in mode of binding. Removal of the amino group at position 3, but not at position 8, on the parent ethidium shortens the lifetime of the intercalative state; this implies that the 3-NH2 group is involved in stabilization of the drug-DNA complex. Analysis of the drug-DNA spectra indicates that there is a preference for binding of the drugs adjacent to G.C base pairs.
利用300兆赫质子核磁共振技术研究了三种乙锭衍生物,即乙锭(1)、去3-氨基乙锭(2)和去8-氨基乙锭(3)与短链(约35个碱基对)随机序列DNA的结合情况。在35摄氏度时,正如预期的与DNA进行嵌入结合那样,所有这三种药物都会使可交换亚氨基质子的共振峰发生上移。然而,线形却因药物的性质而有显著差异。DNA光谱的温度依赖性表明,在35摄氏度下观察到的乙锭和去3-氨基乙锭的光谱差异主要是由于药物结合动力学的不同,而非结合模式的差异。去除母体乙锭上3位而非8位的氨基会缩短嵌入态的寿命;这意味着3-NH₂基团参与了药物-DNA复合物的稳定。对药物-DNA光谱的分析表明,这些药物倾向于结合在G.C碱基对附近。